Real-World Pharmacotherapy-Driven Cardiovascular Risk Prediction Using Interpretable Machine Learning and Jordanian EHR Data
Medical Sciences · 24.06.2026 · 14 (3) · 343
DOI: 10.3390/medsci14030343 ↗Kurz gefasst
Fachartikel in der Zeitschrift Medical Sciences, online erschienen am 24.06.2026. Verfasst von Said Moshawih und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, Faculty of Pharmacy, Al-Ahliyya Amman University, Amman 19111, Jordan. Hauptthemen laut MEDLINE: Electronic Health Records, Cardiovascular Diseases, Machine Learning. Die Arbeit nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Cardiovascular disease (CVD) remains the leading cause of mortality worldwide, with over 75% of deaths occurring in low- and middle-income countries, where conventional risk models often demonstrate poor calibration and limited generalizability.
Objective
This study aimed to develop an interpretable, pharmacotherapy-informed machine learning model for cardiovascular risk prediction using national electronic health record (EHR) data from Jordan.
Methods
A retrospective cohort study was conducted using approximately 600,000 individuals from the national Hakeem EHR system (2018–2022). Demographic, clinical, blood pressure, laboratory, and medication data were integrated to construct three datasets reflecting varying levels of feature completeness. Multiple machine learning models were benchmarked, followed by optimization, hybrid modeling, and probability calibration. Model interpretability was assessed using SHAP analysis.
Results
The national cohort demonstrated a high cardiometabolic burden, with prevalence of hypertension (50.2%), hyperlipidemia (54.9%), and diabetes (47.9%). Antihypertensive and lipid-lowering therapies were more frequently used among CVD patients (56.9% and 49.6%, respectively). Treatment patterns were dominated by amlodipine (19.9%) and atorvastatin (74.4%). The final calibrated seed-bagged gradient boosting model achieved robust performance (ROC-AUC 0.844; PR-AUC 0.813) with consistent generalization across datasets. Key predictors included antihyperlipidemic therapy, systolic blood pressure variability, age, and sex.
Conclusions
This study presents JoRisk, a calibrated and interpretable machine learning framework that integrates pharmacotherapy and clinical data for short-term cardiovascular risk prediction. The model demonstrates strong performance using routinely available EHR variables and offers a scalable decision-support tool for risk stratification in resource-constrained healthcare systems.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmaceutical Sciences, Faculty of Pharmacy, Al-Ahliyya Amman University, Amman 19111, Jordan.
- Department of Pharmacy, Faculty of Pharmacy, Amman Arab University, Mubis 11953, Jordan.
- Department of Biopharmaceutics and Clinical Pharmacy, Faculty of Pharmacy, Al-Ahliyya Amman University, Amman 19111, Jordan.
ORCID-Profile: Said Moshawih, Islam Alfreahat, Abeer Jabra Shnoudeh
Zitieren
APA
Moshawih, S., Gharaibeh, L., Alfreahat, I., & Shnoudeh, A. J. (2026). Real-World Pharmacotherapy-Driven Cardiovascular Risk Prediction Using Interpretable Machine Learning and Jordanian EHR Data. Medical Sciences, 14(3), 343. https://doi.org/10.3390/medsci14030343
Vancouver
Moshawih S, Gharaibeh L, Alfreahat I, Shnoudeh AJ. Real-World Pharmacotherapy-Driven Cardiovascular Risk Prediction Using Interpretable Machine Learning and Jordanian EHR Data. Medical Sciences. 2026;14(3):343. doi:10.3390/medsci14030343
BibTeX
@article{Moshawih2026,
author = {Moshawih, Said and Gharaibeh, Lobna and Alfreahat, Islam and Shnoudeh, Abeer Jabra},
title = {Real-World Pharmacotherapy-Driven Cardiovascular Risk Prediction Using Interpretable Machine Learning and Jordanian EHR Data},
journal = {Medical Sciences},
year = {2026},
volume = {14},
number = {3},
pages = {343},
doi = {10.3390/medsci14030343}
}
EUVIMED